- Home
- PEN vs BEPC Comparison
PEN vs BEPC Comparison
Compare PEN & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- BEPC
- Stock Information
- Founded
- PEN 2004
- BEPC 2019
- Country
- PEN United States
- BEPC United States
- Employees
- PEN N/A
- BEPC N/A
- Industry
- PEN Medical/Dental Instruments
- BEPC Electric Utilities: Central
- Sector
- PEN Health Care
- BEPC Utilities
- Exchange
- PEN Nasdaq
- BEPC Nasdaq
- Market Cap
- PEN 7.0B
- BEPC 5.7B
- IPO Year
- PEN 2015
- BEPC N/A
- Fundamental
- Price
- PEN $243.19
- BEPC $28.29
- Analyst Decision
- PEN Buy
- BEPC Buy
- Analyst Count
- PEN 15
- BEPC 1
- Target Price
- PEN $259.86
- BEPC $34.00
- AVG Volume (30 Days)
- PEN 337.8K
- BEPC 855.2K
- Earning Date
- PEN 10-30-2024
- BEPC 01-31-2025
- Dividend Yield
- PEN N/A
- BEPC 5.02%
- EPS Growth
- PEN N/A
- BEPC N/A
- EPS
- PEN 0.89
- BEPC N/A
- Revenue
- PEN $1,163,776,000.00
- BEPC $4,754,000,000.00
- Revenue This Year
- PEN $13.65
- BEPC $35.62
- Revenue Next Year
- PEN $14.38
- BEPC $6.12
- P/E Ratio
- PEN $273.90
- BEPC N/A
- Revenue Growth
- PEN 16.96
- BEPC 18.32
- 52 Week Low
- PEN $148.00
- BEPC $21.35
- 52 Week High
- PEN $277.34
- BEPC $35.14
- Technical
- Relative Strength Index (RSI)
- PEN 51.31
- BEPC 37.65
- Support Level
- PEN $235.76
- BEPC $29.14
- Resistance Level
- PEN $251.28
- BEPC $29.93
- Average True Range (ATR)
- PEN 7.13
- BEPC 0.99
- MACD
- PEN -1.55
- BEPC -0.25
- Stochastic Oscillator
- PEN 25.79
- BEPC 17.75
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.